You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | 12.9% | -2.5% |
| ROCE | 13.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | 15.6 | 0.0 |
| PEG | 0.2 | -999,999.0 |
| Price / Revenue | 2.7 | 2.9 |
| Price / Book value | 2.2 |
| Latest | Forecast | |
|---|---|---|
| Revenue | -3.6% | -22.5% |
| PBT | 35.2% | n/a |
| EPS | 63.4% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2017-09-30 | 4.10 | -1.91 | -5.70p | -5.9 | 0.0 | n/a | n/a | 0.0% |
| 2018-09-30 | 5.39 | -0.79 | -2.00p | -13.5 | 0.0 | n/a | n/a | 0.0% |
| 2019-09-30 | 7.56 | 0.37 | 0.92p | 55.4 | 0.0 | n/a | n/a | 0.0% |
| 2020-09-30 | 9.53 | 0.86 | 2.02p | 48.0 | 0.4 | 120% | n/a | 0.0% |
| 2021-09-30 | 9.19 | 1.16 | 3.30p | 24.2 | 0.4 | 63% | n/a | 0.0% |
| Ixico tapped for another phase-3 clinical trial Sharecast News | 01 Nov |
|---|---|
| Ixico FY revenues projected to beat expectations Sharecast News | 18 Oct |
| Ixico secures new contract valued at more than $750,000 Sharecast News | 22 Sep |
| Result of AGM | 20-Jan-22 10:50 |
|---|---|
| Huntington’s disease contract update | 20-Jan-22 07:00 |
| Grant of share options | 10-Jan-22 07:00 |
| Financial Results for the year ended 30 Sept 2021 | 07-Dec-21 07:00 |
| Notice of Results | 22-Nov-21 07:00 |